Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights
Amarin Corporation plc (NASDAQ:AMRN) is one of the best performing pharma stocks in 2025.
Amarin Corp Plc (AMRN)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (AMRN) is currently associated with the following stock: Amarin Corp Plc (AMRN)
Sector: Pharmaceutical Preparations
News See All
10 Best Performing Pharma Stocks in 2025
On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and the pharma M&A outlook...
Amarin Corporation plc (NASDAQ:AMRN) Q3 2025 Earnings Call Transcript
Operator: Welcome to Amarin Corporation's conference call to discuss its third quarter 2025 financial results.
Amarin Corporation plc (NASDAQ:AMRN) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Amarin Corporation's Conference Call to discuss its Second Quarter 2025 Financial Results. I would now like to turn the conference over to Mr.
Amarin Corporation plc (NASDAQ:AMRN) Q1 2025 Earnings Call Transcript
Operator: Welcome to Amarin Corporation's Conference Call to discuss its First Quarter 2025 Business Update and Financial Results.
Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript
Operator: Welcome to Amarin Corporation's Conference Call to discuss its Fourth Quarter and Full Year 2024 Business Update and Financial Results.
Amarin Corporation plc (NASDAQ:AMRN) Q3 2024 Earnings Call Transcript
Amarin Corporation plc (NASDAQ:AMRN) Q3 2024 Earnings Call Transcript October 30, 2024Amarin Corporation plc reports earnings inline with expectations.
Amarin Corporation plc (NASDAQ:AMRN) Q2 2024 Earnings Call Transcript
Operator: Welcome to Amarin Corporation’s Conference Call to discuss its Second Quarter 2024 Business Update and Financial Results.
Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript
Amarin Corporation plc misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $-0.0075.
Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript
Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.04.